RhumbLine Advisers’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.39M | Buy |
|
|||||
|
2025
Q4 | $3.42M | Buy |
|
|||||
|
2025
Q3 | $2.12M | Buy |
|
|||||
|
2025
Q2 | $1.47M | Buy |
|
|||||
|
2025
Q1 | $1.4M | Buy |
|
|||||
|
2024
Q4 | $3.02M | Buy |
|
|||||
|
2024
Q3 | $4.47M | Buy |
|
|||||
|
2024
Q2 | $4.29M | Buy |
|
|||||
|
2024
Q1 | $2.79M | Buy |
|
|||||
|
2023
Q4 | $1.01M | Buy |
|
|||||
|
2023
Q3 | $632K | Buy |
|
|||||
|
2023
Q2 | $719K | Buy |
|
|||||
|
2023
Q1 | $590K | Buy |
|
|||||
|
2022
Q4 | $570K | Buy |
|
|||||
|
2022
Q3 | $620K | Buy |
|
|||||
|
2022
Q2 | $305K | Buy |
|
|||||
|
2022
Q1 | $361K | Sell |
|
|||||
|
2021
Q4 | $453K | Sell |
|
|||||
|
2021
Q3 | $623K | Buy |
|
|||||
|
2021
Q2 | $778K | Buy |
|
|||||
|
2021
Q1 | $179K | Buy |
|